Cite
HARVARD Citation
Deakin, B. et al. (n.d.). T108. AUT00206, A NOVEL KV3 CHANNEL MODULATOR, REDUCES KETAMINE-INDUCED BOLD SIGNALLING IN HEALTHY MALE VOLUNTEERS: A RANDOMISED PLACEBO-CONTROLLED CROSSOVER TRIAL. Schizophrenia bulletin. pp. S245-S246. [Online].